This is a community-generated profile. If you would like to claim it, please .

Aveo
Develops targeted cancer therapeutics and markets medicines for cancer patients51-200 EmployeesActively Hiring
Aveo careers
AVEO is a late-stage biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. AVEO's proprietary, integrated cancer biology platform enables the company to pursue highly efficient drug development strategies in oncology that increase the probability of clinical success and provides a discovery engine for high-value targets and therapies. This approach has resulted in a balanced pipeline of novel cancer therapies focused on well-validated targets (VEGFR, EGFR) and promising novel targets (HGF, FGFR, ErbB3 and NOTCH), as well as collaborations with Eli Lilly, Merck, OSI Pharmaceuticals, Schering-Plough, and Biogen Idec. The company was established in 2001 and is based in Cambridge, Massachusetts.
Project Manager II, Technical Operations
In office • Boston
2 weeks ago
John Hurley
Mathematician, developer and data scientist who is using machine learning to identify fraud and other patterns in financial data.
Valuation
$566M
Funded over
1 round
Latest round